Literature DB >> 3467335

Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells.

A R Oseroff, D Ohuoha, G Ara, D McAuliffe, J Foley, L Cincotta.   

Abstract

Carcinoma cell mitochondria preferentially accumulate and retain certain cationic dyes to a much greater extent than most normal cells. Thus, they can potentially serve as targets for highly selective photochemotherapy. We evaluated 10 rhodamine and cyanine dyes as carcinoma-specific mitochondrial photosensitizers in vitro. The most effective, N,N'-bis(2-ethyl-1,3-dioxolane)kryptocyanine (EDKC), caused marked, light-dependent killing of human bladder, squamous, and colon carcinoma cell lines after 30-min incubations at 1-0.01 microM but was minimally toxic to human keratinocytes and to normal monkey kidney epithelial cells (CV-1). Carcinoma cell phototoxicity was proportional to the amount of dye incorporated by the different cell lines. Selective killing ratios were 70-1000 for 0.1 microM dye and light doses of 100-175 J/cm2 between 680 and 720 nm.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467335      PMCID: PMC387214          DOI: 10.1073/pnas.83.24.9729

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cells.

Authors:  D Kessel
Journal:  Biochemistry       Date:  1977-07-26       Impact factor: 3.162

2.  Membrane lysis in Chinese hamster ovary cells treated with hemtoporphyrin derivative plus light.

Authors:  D A Bellnier; T J Dougherty
Journal:  Photochem Photobiol       Date:  1982-07       Impact factor: 3.421

3.  New concepts in therapeutic photomedicine: photochemistry, optical targeting and the therapeutic window.

Authors:  J A Parrish
Journal:  J Invest Dermatol       Date:  1981-07       Impact factor: 8.551

4.  DNA single-strand breaks and sister chromatid exchanges induced by treatment with hematoporphyrin and light or by x-rays in human NHIK 3025 cells.

Authors:  J Moan; H Waksvik; T Christensen
Journal:  Cancer Res       Date:  1980-08       Impact factor: 12.701

5.  Interaction of certain cationic dyes with the respiratory chain of rat liver mitochondria.

Authors:  T E Conover; R F Schneider
Journal:  J Biol Chem       Date:  1981-01-10       Impact factor: 5.157

6.  Increased rhodamine 123 uptake by carcinoma cells.

Authors:  K K Nadakavukaren; J J Nadakavukaren; L B Chen
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

7.  Decreased uptake and retention of rhodamine 123 by mitochondria in feline sarcoma virus-transformed mink cells.

Authors:  L V Johnson; I C Summerhayes; L B Chen
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

8.  Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells.

Authors:  J G Rheinwald; H Green
Journal:  Cell       Date:  1975-11       Impact factor: 41.582

9.  Proliferation of mitochondria during the cell cycle of the human cell line (HL-60).

Authors:  T W James; R Bohman
Journal:  J Cell Biol       Date:  1981-05       Impact factor: 10.539

10.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy.

Authors:  L V Johnson; M L Walsh; B J Bockus; L B Chen
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  18 in total

1.  Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models.

Authors:  Jesung Park; Pawel Mroz; Michael R Hamblin; Anna N Yaroslavsky
Journal:  J Biomed Opt       Date:  2010 Mar-Apr       Impact factor: 3.170

Review 2.  Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.

Authors:  Sunaina Singh; Amit Aggarwal; N V S Dinesh K Bhupathiraju; Gianluca Arianna; Kirran Tiwari; Charles Michael Drain
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

Review 3.  Mitochondrial medicine: pharmacological targeting of mitochondria in disease.

Authors:  J S Armstrong
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

Review 4.  Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells.

Authors:  Halina Mojzisova; Stéphanie Bonneau; Daniel Brault
Journal:  Eur Biophys J       Date:  2007-07-13       Impact factor: 1.733

5.  Photodynamic activity on human larynx epidermoid carcinoma cell line, HEp-2.

Authors:  S Ganesan; V Masilamani
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

6.  Fluorescent cationic probes of mitochondria. Metrics and mechanism of interaction.

Authors:  J R Bunting; T V Phan; E Kamali; R M Dowben
Journal:  Biophys J       Date:  1989-11       Impact factor: 4.033

7.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

Authors:  Ana P Castano; Tatiana N Demidova; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2004-12       Impact factor: 3.631

8.  Mitochondrial permeability transition induced by chemically generated singlet oxygen.

Authors:  Ricardo G Cosso; Jussiani Turim; Iseli L Nantes; Andréa M Almeida; Paolo Di Mascio; Anibal E Verces
Journal:  J Bioenerg Biomembr       Date:  2002-06       Impact factor: 2.945

9.  Porphyrin and galactosyl conjugated micelles for targeting photodynamic therapy.

Authors:  De-Qun Wu; Ze-Yong Li; Cao Li; Jian-Jun Fan; Bo Lu; Cong Chang; Si-Xue Cheng; Xian-Zheng Zhang; Ren-Xi Zhuo
Journal:  Pharm Res       Date:  2009-11-04       Impact factor: 4.200

Review 10.  Mitochondrial targeting of electron scavenging antioxidants: Regulation of selective oxidation vs random chain reactions.

Authors:  Valerian E Kagan; Peter Wipf; Detcho Stoyanovsky; Joel S Greenberger; Grigory Borisenko; Natalia A Belikova; Naveena Yanamala; Alejandro K Samhan Arias; Muhammad A Tungekar; Jianfei Jiang; Yulia Y Tyurina; Jing Ji; Judith Klein-Seetharaman; Bruce R Pitt; Anna A Shvedova; Hülya Bayir
Journal:  Adv Drug Deliv Rev       Date:  2009-08-27       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.